Dynamics of co-infection with M. tuberculosis and HIV-1

Theoretical Population Biology

Volumn 55, Issue 1, 1999, Pages 94-109

  Kirschner, Denise ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SPREAD; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; MODELING; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 0033080472     PISSN: 00405809     EISSN: None     Source Type: Journal    
DOI: 10.1006/tpbi.1998.1382     Document Type: Article

References (46)

1. Antia R., Levin B. R., May R. M. Within-host population dynamics and the evolution and maintenance of microparasite virulence. Am. Nat. 144:1994;457-472.
2. Antia R., Koella J. C., Perrot V. Models of the within-host dynamics of persistent mycobacterial infections. Proc. R. Soc. Lond. B. 1996;257-263.
3. Blower S. M., Small P. M., Howell P. C. Control strategies for tuberculosis epidemics: New models for old problems. Science. 273:1996;497-500.
4. Bryt A. B., Rogers D. E. HIV and TB: An analysis and a course of action. Bull. NY Acad. Med. 71:1994;18-36.
5. Tuberculosis Morbidity. United States, MMWR. 42:1993;. p. 696-704.
6. +. J. Virol. 67:1993;772-1777.
7. Delemarre F. G., Kors N., Kraal G., van Rooijen N. Repopulation of macrophages in popliteal lymph nodes of mice after liposome-meditated depletion. J. Leukocyte Biol. 47:1990;251-257.
8. Dimitrov D. S., Willey R. L., Sato H. Quantiation of HIV-1 infection kinetics. J. Virol. 67:1993;2182-2190.
9. Doedel E. AUTO. Continuation and Bifurcation Software for Ordinary Differential Equations. 1981.
10. Edlin B., Tokars J. I., Gricco M. H. An outbreak of MDR-TB among hospitalized patients with AIDS. New Eng. J. Med. 326:1992;1514-1521.
11. Ermentrout B. XPPAUT3.0. The Differential Equations Tool. 1992.
12. Gittler J. Controlling resurgent TB: Public health agencies, public policy and law. J. Health Pol. 19:1994;107-147.
13. Haase A. T., Henry K., Zupancic M. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science. 274:1996;985-989.
14. +. Nature. 373:1995;123-126.
15. Iseman M. D., Madsen L. A. Drug resistant TB. Clin. Chest Med. 10:1989;341-353.
16. Katz P., Goldstein R. A., Fauci A. S. Immunoregulation in infection caused byM. tuberculosis. J. Infec. Dis. 140:1979;12-21.
17. Kirschner D., Perelson A. A model for the immune system response to HIV: AZT treatment studies. Mathematical Population Dynamics: Analysis of Heterogeneity and Theory of Epidemics. 1995;Wuerz Publishing. p. 296-310.
18. Kirschner D., Webb G. F. A model for treatment strategy in the chemotherapy of AIDS. Bull. Math. Biol. 58:1996;367-390.
19. Kirschner D., Webb G. F. A mathematical model of combined drug therapy of HIV infection. J. Theoret. Med. 1:1997(a);25-34.
20. Kirschner D., Webb G. F. Qualitative differences in HIV chemotherapy between resistance and remission outcomes. Emerging Infect. Dis. 3:1997(b);273-283.
21. Kirschner D., Webb G. F. Understanding drug resistance in the monotherapy treatment of HIV infection. Bull. Math. Biol. 59:1997(c);763-785.
22. Kirschner D., Mehr R., Perelson A. The role of the thymus in adult and pediatric HIV-1 infection. J. AIDS Human Retrov. 18:1988;95-109.
23. Lewis C. E., McGee J. The Macrophage. 1992;IRL Press, Oxford.
24. +. JAIDS. 8:1995;386-391.
25. McLean A. R., Michie C. A. In vivo. Proc. Natl. Acad. Sci. U.S.A. 92:1995;200-205.
26. Meltzer M. S., Skillman D. R., Gomatos P. J. Macrophages and HIV. Immunol. Today. 11:1990;217-233.
27. Narain J. P., Raviglione M. C., Kochi A. HIV-associated TB in developing countries: Epidemiology and strategies for prevention. Tubercle Lung Dis. 73:1992;311-321.
28. Nowak M. A., May R. M., Anderson R. M. The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. AIDS. 4:1990;1095-1103.
29. Nowak M. A., May R. M. Mathematical biology of HIV infections: Antigenic variation and diversity threshold. Math. Biosci. 106:1991;1-21.
30. Nowak M. A., May R. M. Coexistence and competition in HIV infection. J. Theoret. Biol. 159:1992;329-342.
31. Nowak M. A., Bangham C. R. M. Population dynamics of immune responses to persistent viruses. Science. 272:1996;74-79.
32. Orenstein J. M., Fox C., Wahl S. M. Macrophages as a source of HIV during opportunistic infections. Science. 276:1997;1857-1861.
33. Pauza D. HIV persistence in monocytes leads to pathogenesis and AIDS. Cellular Immunol. 112:1989;1-11.
34. Perelson A. S. Modeling the interaction of the immune system with HIV. Castillo-Chavez C. Mathematical and Statistical Approaches to AIDS Epidemiology. Lecture Notes in Biomath. 83:1989;350-370 Springer-Verlag, New York.
35. +. Math. Biosci. 114:1993;81-125.
36. Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M., Ho D. D. HIV-1 dynamics in vivo: Virion clearance rate, infected cell lifespan, and viral generation time. Science. 271:1996;1582-1586.
37. Pfuetze K. H., Rander D. B. Clinical Tuberculosis. 1966;Thomas, Springfield.
38. Selwyn P. A., Hartel D., Lewis V. A. A prospective study of the risk of TB among IV-drug users with HIV. New Eng. J. Med. 320:1989;545-550.
39. Shafer R. W., Bloch A. B., Larkin C. Predictors of survival in HIV-infected tuberculosis patients. AIDS. 10:1996;269-272.
40. Tanaka Y., Morita C. T., Tanaka Y. Natural and synthetic non-peptide antigens recognized by humanγδ Nature. 375:1995;155-158.
41. Torres R. A., Mani S., Altholz J., Brickner P. W. HIV infection among homeless men in a NYC shelter-association with TB infection. Arch. Intern. Med. 150:1990;2030-2036.
42. Tough D. F., Sprent J. Lifespan of lymphocytes. Immunol. Res. 14:1995;1-12.
43. Vareldzis B. P., Grosset J., de Kantor I. Drug resistant TB-laboratory issues. Tubercle Lung Dis. 75:1989;1-7.
44. +, Division of Preventitive Medicine Report.
45. Treatment of TB: Guidelines for National Programmes. 1983;World Health Organization, Geneva. p. 1-43.
46. Youmans G. P. Tuberculosis. 1979;W. B. Sanders Co. London.